1. Home
  2. YELP vs AGIO Comparison

YELP vs AGIO Comparison

Compare YELP & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YELP
  • AGIO
  • Stock Information
  • Founded
  • YELP 2004
  • AGIO 2007
  • Country
  • YELP United States
  • AGIO United States
  • Employees
  • YELP N/A
  • AGIO N/A
  • Industry
  • YELP Other Consumer Services
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • YELP Consumer Discretionary
  • AGIO Health Care
  • Exchange
  • YELP Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • YELP 2.1B
  • AGIO 2.4B
  • IPO Year
  • YELP 2012
  • AGIO 2013
  • Fundamental
  • Price
  • YELP $29.29
  • AGIO $43.37
  • Analyst Decision
  • YELP Hold
  • AGIO Strong Buy
  • Analyst Count
  • YELP 4
  • AGIO 4
  • Target Price
  • YELP $32.00
  • AGIO $59.33
  • AVG Volume (30 Days)
  • YELP 791.0K
  • AGIO 568.5K
  • Earning Date
  • YELP 11-06-2025
  • AGIO 10-30-2025
  • Dividend Yield
  • YELP N/A
  • AGIO N/A
  • EPS Growth
  • YELP 37.30
  • AGIO N/A
  • EPS
  • YELP 2.25
  • AGIO N/A
  • Revenue
  • YELP $1,466,918,000.00
  • AGIO $44,791,000.00
  • Revenue This Year
  • YELP $6.16
  • AGIO $25.57
  • Revenue Next Year
  • YELP $3.80
  • AGIO $153.24
  • P/E Ratio
  • YELP $13.00
  • AGIO N/A
  • Revenue Growth
  • YELP 5.34
  • AGIO 36.26
  • 52 Week Low
  • YELP $27.91
  • AGIO $23.42
  • 52 Week High
  • YELP $41.72
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • YELP 35.39
  • AGIO 59.98
  • Support Level
  • YELP $27.91
  • AGIO $39.38
  • Resistance Level
  • YELP $34.49
  • AGIO $44.10
  • Average True Range (ATR)
  • YELP 1.13
  • AGIO 1.79
  • MACD
  • YELP -0.43
  • AGIO -0.14
  • Stochastic Oscillator
  • YELP 22.07
  • AGIO 85.23

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: